Catheter Precision Inc (VTAK) USD0.0001

Sell:$0.29Buy:$0.31$0.01 (2.75%)

Prices delayed by at least 15 minutes
Sell:$0.29
Buy:$0.31
Change:$0.01 (2.75%)
Prices delayed by at least 15 minutes
Sell:$0.29
Buy:$0.31
Change:$0.01 (2.75%)
Prices delayed by at least 15 minutes

Company Information

About this company

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing a kit of tools to enable physicians to gain access to the pericardial space of the heart.

Key people

David A. Jenkins
Executive Chairman of the Board, Chief Executive Officer
Philip J. Anderson
Chief Financial Officer
Margrit Thomassen
Company Controller
Marie-Claude Jaques
Chief Commercial Officer
James J. Caruso
Independent Director
Martin J. Colombatto
Independent Director
Click to see more

Key facts

  • EPIC
    VTAK
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US74933X6094
  • Market cap
    $2.97m
  • Employees
    22
  • Shares in issue
    9.27m
  • Exchange
    Nyse American LLC
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.